In the BioHarmony Drug Report Database

"Preview" Icon

Perindopril arginine

Prestalia (perindopril arginine) is a small molecule pharmaceutical. Perindopril arginine was first approved as Prestalia on 2015-01-21. It is used to treat diabetic nephropathies, heart failure, hypertension, and left ventricular dysfunction in the USA. Prestalia’s patent is valid until 2029-10-05 (FDA).

 

Trade Name

 

Prestalia
 

Common Name

 

perindopril arginine
 

ChEMBL ID

 

CHEMBL3544986
 

Indication

 

diabetic nephropathies, heart failure, hypertension, left ventricular dysfunction
 

Drug Class

 

Antihypertensives (ACE inhibitors)

Image (chem structure or protein)

Perindopril arginine structure rendering